Publicaciones en las que colabora con HOURIA BOULAIZ (31)

2023

  1. Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma

    Cancers, Vol. 15, Núm. 14

2020

  1. miRNAs as radio-response biomarkers for breast cancer stem cells

    Molecular Oncology, Vol. 14, Núm. 3, pp. 556-570

2019

  1. Deciphering the mechanism of action involved in enhanced suicide gene colon cancer cell killer effect mediated by gef and apoptin

    Cancers, Vol. 11, Núm. 2

  2. Melanoma cancer stem-like cells: Optimization method for culture, enrichment and maintenance

    Tissue and Cell, Vol. 60, pp. 48-59

2018

  1. Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile

    Cancer Letters, Vol. 429, pp. 78-88

2017

  1. Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism

    Expert Reviews in Molecular Medicine, Vol. 19

  2. Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity

    Scientific Reports, Vol. 7

2016

  1. Cancer suicide gene therapy: a patent review

    Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 9, pp. 1095-1104

  2. Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what’s new?

    Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 8, pp. 877-890

2014

  1. HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound

    Oncotarget, Vol. 5, Núm. 11, pp. 3590-3606

2012

  1. Purification and long-term expansion of multipotent endothelial-like cells with potential cardiovascular regeneration

    Stem Cells and Development, Vol. 21, Núm. 4, pp. 562-574

  2. Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy

    Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 (Springer Netherlands), pp. 157-171

2011

  1. Development of patents and clinical trials on regenerative therapy: Gene therapy

    Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 182-194

  2. Nanomedicine: Application areas and development prospects

    International Journal of Molecular Sciences, Vol. 12, Núm. 5, pp. 3303-3321

  3. Regenerative therapies in cartilage and bone: Current patents, technologies, and emerging applications

    Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 134-141

  4. Ultrastructural and molecular analyzes of insulin-producing cells induced from human hepatoma cells

    Cytotherapy, Vol. 13, Núm. 2, pp. 193-200

  5. gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway

    International Journal of Molecular Sciences, Vol. 12, Núm. 11, pp. 7445-7458

2010

  1. Differentiation of intestinal epithelial cells mediated by cell confluence and/or exogenous nucleoside supplementation

    Cells Tissues Organs, Vol. 191, Núm. 6, pp. 478-488

  2. Promotion of human adipose-derived stem cell proliferation mediated by exogenous nucleosides

    Cell Biology International, Vol. 34, Núm. 9, pp. 917-924

  3. Transfection of the gene e and later application of cytotoxic drugs in the treatment of breast multicellular tumour solid cancer

    EJC SUPPLEMENTS